Asia Pacific Drug Delivery System Market to 2027 - Regional Analysis and Forecasts by Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others) and Country
Publication Month: Oct 2019
Report Code: TIPRE00006839 No. of Pages: 223 Category: Medical Device Status: Published
The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.
The key factors that are driving the growth of the market are rising incidence of chronic diseases, and growing demand for non-invasive drug delivery devices. However, the factors restraining the market growth are high R&D cost involved in product development. Whereas, high cost for developing drug delivery devices is likely to have a negative impact on the growth of the market in the coming years.
In Asia Pacific, various routes of administration are being studied in order to treat these chronic diseases. According to the estimates by The Asia Pacific Burden of Disease, the death rate of CVD is approximately 272 per 100,000 people in India, which is comparatively higher than the Asia Pacific average (i.e., 235 per 100 000 population). Similar trends for the increased prevalence of diabetes is witnessed among Asian countries such as Australia, China, South Korea, and Australia. For instance, as per IDF Diabetes Atlas published by the International Diabetes Federation in 2017, South-East Asia consists of almost one-fifth (19%) of the Asia Pacific diabetes population. As per the data published by the World Health Organization (WHO), in 2014, around 230 million people in China had CVD. Also, by 2030, the number is predicted to increase by 50% considering the aging Chinese population and growth. Additionally, by 2030, cardiovascular disease will cost $ 1,044 billion to the Chinese government. Rising geriatric population and related chronic diseases are expected to drive the sales of medical devices, hence leading to the growth of the market in the Asia Pacific over the forecast years. The problem of growing prevalence of cancer is increasing in APAC. The region reports Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia as the top 15 countries with cancer prevalence. Owing to Increasing Chronic Diseases Cases, the drug delivery systems market is likely to propel the growth in the forecast period.
China is anticipated to lead the adoptions of drug delivery systems across the Asia Pacific region through the forecast period. Growing research activities in drug delivery technology, increasing significant prevalence of disease and rising number of collaborations and partnerships in advance science and innovation. China is also expected to provide lucrative opportunities to local as well as international players to manufacture and market drug delivery devices in the country over the forecast years.
Get more information on this report : China Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Asia Pacific Drug Delivery Systems Market Segmentation
By Route of Administration
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
- Hospital & Clinics
- Home Care Settings
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
- China
- Japan
- India
Companies Mentioned
- 3M
- MYLAN N.V.
- ABBOTT
- F. HOFFMANN-LA ROCHE AG
- JOHNSON & JOHNSON
- NOVARTIS
- ANTARES PHARMA
- BAXTER
- MERCK & CO., INC.
- BECTON, DICKINSON AND COMPANY
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Drug Delivery Systems Market – Key Takeaways
3. Asia Pacific Drug Delivery Systems Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia Pacific Drug Delivery Systems Market – By Route Of Administration
3.2.2 Asia Pacific Drug Delivery Systems Market – By Application
3.2.3 Asia Pacific Drug Delivery Systems Market – By Distribution Channel
3.2.4 Asia Pacific Drug Delivery Systems Market – By Geography
3.3 Pest Analysis
4. Asia Pacific Drug Delivery Systems Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Chronic Diseases Cases Across World
4.1.2 Adoption For Non-Invasive Drug Delivery Devices Is Growing
4.2 Key Market Restraints
4.2.1 Developing Drug Delivery Devices Requires High Cost
4.3 Key Market Opportunities
4.3.1 Growing Patient Compliance
4.4 Future Trends
4.4.1 Increasing Developments And Innovations In Drug Delivery Technology
4.5 Impact Analysis
5. Drug Delivery Systems Market – Asia Pacific Analysis
5.1 Asia Pacific Drug Delivery Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
6. Asia Pacific Drug Delivery Systems Market Analysis – By Route Of Administration
6.1 Overview
6.2 Route Of Administration Market Revenue And Forecasts Analysis (US$ Mn)
6.3 Oral Drug Delivery Market
6.3.1 Overview
6.3.2 Oral Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.3.3 Solid Oral Drugs Market
6.3.3.1 Overview
6.3.3.2 Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.3.3.3 Solid Oral Drugs Market Revenue And Forecasts To 2027 (Us$ Mn)
6.3.4 Liquid Oral Drugs Market
6.3.4.1 Overview
6.3.4.2 Liquid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.3.4.3 Liquid Oral Drugs Market Revenue And Forecasts To 2027 (Us$ Mn)
6.3.5 Semi-Solid Oral Drugs Market
6.3.5.1 Overview
6.3.5.2 Semi-Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)
6.3.5.3 Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (Us$ Mn)
6.4 Transmucosal Drug Delivery Market
6.4.1 Overview
6.4.2 Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.4.3 Pulmonary Drug Delivery Market
6.4.3.1 Overview
6.4.3.2 Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.3.3 Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
6.4.3.4 In-Metered Dose Inhalers Market
6.4.3.4.1 Overview
6.4.3.4.2 In-Metered Dose Inhalers Market Revenue And Forecast To 2027 (US$ Mn)
6.4.3.5 Dry Powder Inhalers Market
6.4.3.5.1 Overview
6.4.3.5.2 Dry Powder Inhalers Market Revenue And Forecast To 2027 (US$ Mn)
6.4.3.6 Nebulizers Market
6.4.3.6.1 Overview
6.4.3.6.2 Nebulizers Market Revenue And Forecast To 2027 (US$ Mn)
6.4.4 Nasal Drug Delivery Market
6.4.4.1 Overview
6.4.4.2 Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.4.3 Nasal Spray Market
6.4.4.3.1 Overview
6.4.4.3.2 Nasal Spray Market Revenue And Forecast To 2027 (US$ Mn)
6.4.4.4 Nasal Drops Market
6.4.4.4.1 Overview
6.4.4.4.2 Nasal Drops Market Revenue And Forecast To 2027 (US$ Mn)
6.4.4.5 Nasal Gel Market
6.4.4.5.1 Overview
6.4.4.5.2 Nasal Gel Market Revenue And Forecast To 2027 (US$ Mn)
6.4.5 Buccal Drug Delivery Market
6.4.5.1 Overview
6.4.5.2 Buccal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.6 Sublingual Drug Delivery Market
6.4.6.1 Overview
6.4.6.2 Sublingual Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.7 Rectal Transmucosal Drug Delivery Market
6.4.7.1 Overview
6.4.7.2 Rectal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.4.8 Vaginal Transmucosal Drug Delivery Market
6.4.8.1 Overview
6.4.8.2 Vaginal Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
6.5 Topical Drug Delivery Market
6.5.1 Overview
6.5.2 Topical Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.5.3 Semi-Solid Topical Drug Delivery Formulations Market
6.5.3.1 Overview
6.5.3.2 Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.5.4 Liquid Topical Drug Delivery Formulations Market
6.5.4.1 Overview
6.5.4.2 Liquid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.5.5 Solid Topical Drug Delivery Formulations Market
6.5.5.1 Overview
6.5.5.2 Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)
6.5.6 Transdermal Patches Market
6.5.6.1 Overview
6.5.6.2 Transdermal Patches Market Revenue And Forecast To 2027 (US$ Mn)
6.5.7 Transdermal Gels Market
6.5.7.1 Overview
6.5.7.2 Transdermal Gels Market Revenue And Forecast To 2027 (US$ Mn)
6.5.8 Others Market
6.5.8.1 Overview
6.5.8.2 Others Market Revenue And Forecast To 2027 (US$ Mn)
6.6 Injectable Drug Delivery Market
6.6.1 Overview
6.6.2 Injectable Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.6.3 Conventional Injection Devices Market
6.6.3.1 Overview
6.6.3.2 Conventional Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
6.6.4 Self-Injection Devices Market
6.6.4.1 Overview
6.6.4.2 SELF-INJECTION Devices Market Revenue And Forecast To 2027 (US$ Mn)
6.6.4.3 Needle Free Injectors Market
6.6.4.3.1 Overview
6.6.4.3.2 Needle Free Injectors Market Revenue And Forecast To 2027 (US$ Mn)
6.6.4.4 Pen Injectors Market
6.6.4.4.1 Overview
6.6.4.4.2 Pen Injectors Market Revenue And Forecast To 2027 (US$ Mn)
6.6.4.5 Wearable Injectors Market
6.6.4.5.1 Overview
6.6.4.5.2 Wearable Injectors Market Revenue And Forecast To 2027 (US$ Mn)
6.7 Implantable Drug Delivery Market
6.7.1 Overview
6.7.2 Implantable Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.7.3 Active Implantable Market
6.7.3.1 Overview
6.7.3.2 Active Implantable Market Revenue And Forecast To 2027 (US$ Mn)
6.7.4 Passive Implantable Market
6.7.4.1 Overview
6.7.4.2 Passive Implantable Market Revenue And Forecast To 2027 (US$ Mn)
6.8 Ocular Drug Delivery Market
6.8.1 Overview
6.8.2 Ocular Drug Delivery Market Revenue And Forecast To 2027 (Us$ Mn)
6.8.3 Eye Drops And Sprays Market
6.8.3.1 Overview
6.8.3.2 Eye Drops And Sprays Market Revenue And Forecast To 2027 (US$ Mn)
6.8.4 Gels & Ointments Market
6.8.4.1 Overview
6.8.4.2 Gels & Ointments Market Revenue And Forecast To 2027 (US$ Mn)
6.8.5 Ocular Inserts Market
6.8.5.1 Overview
6.8.5.2 Ocular Inserts Market Revenue And Forecast To 2027 (US$ Mn)
6.8.6 Drug Coated Contact Lens Market
6.8.6.1 Overview
6.8.6.2 Drug Coated Contact Lens Market Revenue And Forecast To 2027 (US$ Mn)
7. Asia Pacific Drug Delivery Systems Market Analysis – By Distribution Channel
7.1 Overview
7.2 Asia Pacific Drug Delivery Systems MARKET, By Distribution Channel 2018 & 2027 (%)
7.3 Hospital Pharmacies Market
7.3.1 Overview
7.3.2 Asia Pacific Hospital Pharmacies Market Revenue And Forecasts To 2027 (Us$ Mn)
7.4 Retail Pharmacies Market
7.4.1 Overview
7.4.2 Asia Pacific Retail Pharmacies Market Revenue And Forecasts To 2027 (Us$ Mn)
7.5 Online Pharmacies Market
7.5.1 Overview
7.5.2 Asia Pacific Online Pharmacies Market Revenue And Forecasts To 2027 (Us$ Mn)
8. Asia Pacific Drug Delivery Systems Market Analysis – By Application
8.1 Overview
8.2 Asia Pacific Drug Delivery Systems MARKET, By Applicaton 2018 & 2027 (%)
8.3 Homecare Settings Market
8.3.1 Overview
8.3.2 Asia Pacific Homecare Settings Market Revenue And Forecasts To 2027 (Us$ Mn)
8.4 Hospitals & Clinics Market
8.4.1 Overview
8.4.2 Asia Pacific Hospitals & Clinics Market Revenue And Forecasts To 2027 (Us$ Mn)
8.5 Others Market
8.5.1 Overview
8.5.2 Asia Pacific Others Market Revenue And Forecasts To 2027 (Us$ Mn)
9. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027
9.1 Asia Pacific Drug Delivery Systems Market
9.1.1 Overview
9.1.2 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.3 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (Us$ Mn)
9.1.3.1 Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.2 Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.3 Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.4 Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.5 Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.6 Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.7 Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.3.8 Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.4 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (Us$ Mn)
9.1.5 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (Us$ Mn)
9.1.6 Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
9.1.7 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.8 China Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.8.1 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.8.1.1 China Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.2 China Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.3 China Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.4 China Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.5 China Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.6 China Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.7 China Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.8 China Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.1.9 China Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.8.2 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.8.3 China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
9.1.9 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.10 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.10.1 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.10.1.1 Japan Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.2 Japan Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.3 Japan Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.4 Japan Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.5 Japan Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.6 Japan Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.7 Japan Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.8 Japan Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.1.9 Japan Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.10.2 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.10.3 Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
9.1.11 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.12 India Drug Delivery Systems Market Revenue And Forecasts To 2027 (Us$ Mn)
9.1.12.1 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
9.1.12.1.1 India Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.2 India Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.3 India Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.4 India Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.5 India Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.6 India Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.7 India Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.8 India Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.1.9 India Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.1.12.2 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.1.12.3 India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
10. Drug Delivery Systems Market –Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Drug Delivery Systems Market–Key Company Profiles
11.1 3m
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 BD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novo Nordisk A/S
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bausch Health Companies Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Baxter International, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Boehringer Ingelheim International Gmbh
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Novartis AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Glaxosmithkline Plc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Terumo Corporation
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Johnson & Johnson Services, Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 2. Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 3. Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 5. Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 6. Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 8. Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 9. Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 10. Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 12. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 13. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 14. China Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. China Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 16. China Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 17. China Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 18. China Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. China Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 20. China Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 21. China Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 22. China Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 24. China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 25. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 26. Japan Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 27. Japan Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 28. Japan Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 29. Japan Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 30. Japan Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 31. Japan Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 32. Japan Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 33. Japan Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 34. Japan Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 35. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 36. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 37. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
Table 38. India Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 39. India Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 40. India Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 41. India Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 42. India Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 43. India Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 44. India Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 45. India Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 46. India Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 47. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 48. India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 49. Organic Developments Done By Companies
Table 50. Inorganic Developments Done By Companies
Table 51. Glossary Of Terms, Drug Delivery Systems Market
LIST OF FIGURES
Figure 1. China Drug Delivery Systems Market, Revenue (US$ Mn), By 2018 & 2027
Figure 2. Asia Pacific Drug Delivery Systems Market By Type, Market Share (%), 2018
Figure 3. Asia Pacific Drug Delivery Systems Market By Application, Market Share (%), 2018
Figure 4. Asia Pacific Drug Delivery Systems Market By Distribution Channels, Market Share (%), 2018
Figure 5. Drug Delivery Systems Market Segmentation
Figure 6. Asia Pacific PEST Analysis
Figure 7. Drug Delivery Systems Market Impact Analysis Of Driver And Restraints
Figure 8. Asia Pacific Drug Delivery Systems Market – Revenue Forecasts And Analysis –2018- 2027
Figure 9. Route Of Administration MARKET Analysis And Forecasts 2018 And 2027 (%)
Figure 10. Oral Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Transmucosal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. In-Metered Dose Inhalers Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 13. Dry Powder Inhalers Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 14. Nebulizers Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 15. Nasal Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 16. Nasal Spray Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 17. Nasal Spray Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 18. Nasal Gel Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 19. Buccal Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 20. Sublingual Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 21. Rectal Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 22. Vaginal Drug Delivery Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 23. Topical Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 25. Liquid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 26. Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 27. Transdermal Patches Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 28. Transdermal Gels Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 29. Others Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 30. Injectable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Conventional Injection Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 32. Self-Injection Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 33. Needle Free Injectors Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 34. Pen Injectors Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 35. Wearable Injectors Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 36. Implantable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 37. Active Implantable Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 38. Passive Implantable Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 39. Ocular Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 40. Eye Drops And Spray Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 41. Gels & Ointments Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 42. Ocular Inserts Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 43. Drug Coated Contact Lens Market Revenue And Forecasts To 2027 (Us$ Mn)
Figure 44. Asia Pacific Drug Delivery Systems Market Breakdown, By End User 2018 & 2027 (%)
Figure 45. Asia Pacific HOSPITAL PHARMACIES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 46. Asia Pacific RETAIL PHARMACIES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 47. Asia Pacific Online PHARMACIES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 48. Asia Pacific Drug Delivery Systems Market Breakdown, By Application 2018 & 2027 (%)
Figure 49. Asia Pacific Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 50. Asia Pacific Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 51. Asia Pacific Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 52. Asia Pacific Drug Delivery Systems Market Revenue Overview, By Country (2018) (Us $ Mn)
Figure 53. Asia Pacific Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 54. Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)
Figure 55. China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 56. Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 57. India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 58. Comparative Company Analysis
Figure 59. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies
- 3M
- Mylan N.V.
- Abbott
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis
- Antares Pharma
- Baxter
- Merck & Co., Inc.
- Becton, Dickinson And Company
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Drug delivery system market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Drug delivery system market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.